123 related articles for article (PubMed ID: 37673624)
1. [Granulocyte-colony stimulating factor-producing multiple myeloma presenting with neutrophilia].
Yokoi M; Kondo T; Shimizu R; Uchida K; Hayashi S; Nishimura H; Kondo E; Wada H
Rinsho Ketsueki; 2023; 64(8):735-740. PubMed ID: 37673624
[TBL] [Abstract][Full Text] [Related]
2. [Granulocyte-colony stimulating factor-producing myeloma with clinical manifestations mimicking chronic neutrophilic leukemia].
Kusaba N; Yoshida H; Ohkubo F; Mishima K; Shimamastu K; Okamura T; Sata M
Rinsho Ketsueki; 2004 Mar; 45(3):228-32. PubMed ID: 15103937
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony stimulating factor-producing multiple myeloma associated with neutrophilia.
Kohmura K; Miyakawa Y; Kameyama K; Kizaki M; Ikeda Y
Leuk Lymphoma; 2004 Jul; 45(7):1475-9. PubMed ID: 15359652
[TBL] [Abstract][Full Text] [Related]
4. A case of multiple myeloma producing granulocyte colony-stimulating factor.
Usuda H; Naito M; Ohyach K; Iizumi T
Pathol Int; 1997 Dec; 47(12):866-9. PubMed ID: 9503469
[TBL] [Abstract][Full Text] [Related]
5. Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone.
Sun HL; Atenafu EG; Yeboah E; Reece DE; Trudel S; Kukreti V; Masih-Khan E; Winter A; Chen C
Leuk Lymphoma; 2015 Feb; 56(2):407-14. PubMed ID: 24738975
[TBL] [Abstract][Full Text] [Related]
6. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte Colony-stimulating Factor Producing Anaplastic Carcinoma of the Pancreas: Case Report and Review of the Literature.
Vinzens S; Zindel J; Zweifel M; Rau T; Gloor B; Wochner A
Anticancer Res; 2017 Jan; 37(1):223-228. PubMed ID: 28011495
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte Colony-stimulating Factor Producing Oropharyngeal Squamous Cell Carcinoma.
Schurmann G; Zweifel M; Giger R; Rau TT; Vinzens S; Dettmer MS; Kurian Y
In Vivo; 2021; 35(3):1785-1790. PubMed ID: 33910863
[TBL] [Abstract][Full Text] [Related]
11. A case of granulocyte-colony-stimulating factor-producing gallbladder cancer with lymph node metastasis together with a literature review.
Tohyama T; Hosobe H; Kobayashi T; Murakami T; Fujimoto Y; Hayashi T; Matsumoto T; Asakawa T; Omori M
Clin J Gastroenterol; 2023 Oct; 16(5):732-742. PubMed ID: 37258993
[TBL] [Abstract][Full Text] [Related]
12. Radical esophagectomy for a 92-year-old woman with granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma: a case report.
Kitani M; Yamagata Y; Tanabe A; Yagi K; Aikou S; Kiyokawa T; Nishida M; Yamashita H; Mori K; Nomura S; Seto Y
World J Surg Oncol; 2016 Oct; 14(1):264. PubMed ID: 27737660
[TBL] [Abstract][Full Text] [Related]
13. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
Sallerfors B; Olofsson T; Lenhoff S
Bone Marrow Transplant; 1991 Sep; 8(3):191-5. PubMed ID: 1720339
[TBL] [Abstract][Full Text] [Related]
15. A case of granulocyte-colony stimulating factor producing gallbladder cancer.
Omura N; Abe S; Hirai K; Aoki T
Am J Gastroenterol; 1999 Jan; 94(1):273-5. PubMed ID: 9934773
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study.
Kim JS; Yoon DH; Park S; Yoon SS; Cho SG; Min CK; Lee JJ; Yang DH; Kwak JY; Eom HS; Kim WS; Kim H; Do YR; Moon JH; Lee J; Suh C
Ann Hematol; 2016 Mar; 95(4):603-11. PubMed ID: 26754633
[TBL] [Abstract][Full Text] [Related]
17. Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF.
Jang JE; Cheong JW; Kim SJ; Cho H; Suh C; Lee H; Eom HS; Yhim HY; Lee WS; Min CK; Lee JH; Park JS; Kim JS
Leuk Lymphoma; 2016; 57(6):1389-97. PubMed ID: 26428939
[TBL] [Abstract][Full Text] [Related]
18. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
19. Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials.
Chhabra S; Callander N; Watts NL; Costa LJ; Thapa B; Kaufman JL; Laubach J; Sborov DW; Reeves B; Rodriguez C; Chari A; Silbermann R; Anderson LD; Bal S; Dhakal B; Nathwani N; Shah N; Medvedova E; Bumma N; Holstein SA; Costello C; Jakubowiak A; Wildes TM; Schmidt T; Orlowski RZ; Shain KH; Cowan AJ; Dholaria B; Cornell RF; Jerkins JH; Pei H; Cortoos A; Patel S; Lin TS; Usmani SZ; Richardson PG; Voorhees PM
Transplant Cell Ther; 2023 Mar; 29(3):174.e1-174.e10. PubMed ID: 36494017
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor-producing ascending colon cancer as indicated by histopathological findings: report of a case.
Fujiwara Y; Yamazaki O; Takatsuka S; Kaizaki R; Inoue T
Osaka City Med J; 2011 Dec; 57(2):79-84. PubMed ID: 22443081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
